Research

$3.5 million funds study aimed at applying precision medicine to rare tumor disorder

Washington University School of Medicine in St. Louis •
David Gutmann, MD, PhD, speaks with patient Sarah Bess and Stephanie Morris, MD, at the Neurofibromatosis Center at Washington University School of Medicine in St. Louis. Gutmann has received a grant to study the roots of the diversity of symptoms experienced by people with the genetic disorder. (Photo: Robert Boston/School of Medicine)
View Content

An international leader in neurofibromatosis research has received a $3.5 million grant to study why people with the same genetic mutation – in this case, a mutation that causes the genetic disorder known as neurofibromatosis type 1 (NF1) – develop markedly different signs and symptoms.